Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult acute lymphoblastic leukemia

Blood

Volumn 95, Issue 7, 2000, Pages 2364-2371

  Stock, Wendy ^b   Tsai, Tsuong ^b   Golden, Carla ^b   Rankin, Cathy ^b   Sher, Dorrie ^b   Slovak, Marilyn L ^b   Pallavicini, Maria G ^b   Radich, Jerald P ^b   Boldt, David H ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; IMMUNOCYTOCHEMISTRY; LEUKEMOGENESIS; LYMPHOBLAST; MALE; PRIORITY JOURNAL; REGULATOR GENE; STEM CELL; SURVIVAL;

ADOLESCENT; ADULT; AGED; BONE MARROW; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL SEPARATION; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; FLOW CYTOMETRY; GENES, P53; GENES, RETINOBLASTOMA; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; MUTATION; REMISSION INDUCTION; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEINS;

EID: 0034177523     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukemia in adults. Blood. 1995;85:1151-1168.
2. Laport GF, Larson RA. Treatment of adult acute lymphoblastic leukemia. Semin Oncol. 1997;24: 70-82.
3. Thandla S, Aplan PD. Molecular biology of acute lymphocytic leukemia. Semin Oncol. 1997;24: 45-56.
4. Faderl S, Kantarjian H, Talpaz M, Estrov Z. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood. 1998; 91:3995-4019.
5. Petersdorf S, Kopecky KJ, Head D, Boldt D, Appelbaum F. A comparison of two consolidation regimens in the treatment of adult acute lymphoblastic leukemia (ALL): the results of the Southwest Oncology Group studies (SWOG) 8417/19. Blood. 1993;82(suppl 1):193a.
6. Head DR, Savage RA, Cerezo L, et al. Reproducibility of the French-American-British classification of acute leukemia: the Southwest Oncology Group experience. Am J Hematol. 1985;18: 47-57.
7. Schauer P, Arlin ZA, Mertelsman R, et al. Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols. J Clin Oncol. 1983;1:462-470.
8. Boldt DH, Kopecky KJ, Head D, Gehly G, Radich JP, Appelbaum FR. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults: the Southwest Oncology Group experience. Leukemia. 1994;8:2118-2126.
9. Radich JP, Kopecky KJ, Boldt DH, et al. Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction. Leukemia. 1994;8:1688-1695.
10. Tsai T, Davalath S, Rankin C, et al. Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL): analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies. Leukemia. 1996;10:1901-1910.
11. Myers RM, Larin Z, Maniatis T. Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA:DNA duplexes. Science. 1985;230:1242-1246.
12. Winter E, Yamamoto F, Almohuera C, Perucho M. A method to detect and characterize point mutations in transcribed genes. Proc Natl Acad Sci U S A. 1985;82:7575-7579.
13. Westbrook CA, Hooberman AL, Spino C, et al. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). Blood. 1992;80:2983-2990.
14. Apian PD, Lombardi DP, Reaman GH, Sather HN, Hammond GD, Kirsch IR. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood. 1992; 79:1327-1333.
15. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994;264:436-440.
16. Nobori T, Miura K, Wu DJ, et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 1994;368:753-756.
17. Mehrota B, George TI, Kavanu K, et al. Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia. Blood. 1995;86:1139-1147.
18. Quijano CA, Moore D II, Arthur D, Feusner J, Winter SS, Pallavicini MG. Cytogenetically aberrant cells are present in the CD34+CD33-38-19-marrow compartment in children with acute lymphoblastic leukemia. Leukemia. 1997;11:1508-1515.
19. Wilcoxon F. Individual comparisons by ranking methods. Biometrics. 1945;1:80.
20. Cox DR. Analysis of binary data. London: Chapman and Hall; 1970.
21. Cytel Software Corporation. Stat Xact user manual. Cambridge: Cytel Software Corporation; 1989.
22. Feinberg SE. The analysis of cross-classified categorical data. Cambridge: MIT Press; 1977.
23. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
24. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley; 1980.
25. Drexler HG. Review of the alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18, and p19 in human leukemia-lymphoma cells. Leukemia. 1998;12:854-859.
26. Stock W, Sher D, Dodge R, et al. Transcriptional silencing is an alternative means of p16 inactivation: further evidence for p16 role in pathogenesis of adult acute lymphoblastic leukemia (ALL) - a Cancer and Leukemia Group B Study. ASCO Proc.1997;16:552a.
27. Sherr CJ. Cancer cell cycles. Science. 1996;274: 1672-1677.
28. Demers GW, Foster SA, Haibert CL, Galloway DA. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc Natl Acad Sci U S A. 1994;91:4382-4386.
29. Slebas RJC, Lee MH, Plunkett BS, et al. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by human papillomavirus E7 oncoprotein. Proc Natl Acad Sci U S A. 1994;91: 5320-5324.
30. INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood. 1996;87:4949-4958.
31. Szilvassy SJ, Cory S. Phenotypic and functional characterization of competitive long-term repopulating hematopoietic stem cells enriched from 5-fluorouracil-treated murine marrow. Blood. 1993;81:2310-2320.
32. Stewart FM, Temeles D, Lowry P, Thraves T, Gross WW, Quesenberry PJ. Post-5-fluorouracil human marrow: stem cell characteristics and renewal properties after autologous marrow transplantation. Blood. 1993;81:2283-2289.
33. Uckun FM, Jaszcz W, Chandan-Langlie M, Waddick KG, Gajl-Peczalska K, Song CW. Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia. J Clin Invest. 1993;91:1044-1051.
34. Zanjari ED, Srour EF, Hoffman R. Retention of long-term repopulating ability of xenogeneic transplanted purified adult human bone marrow hematopoietic stem cells in sheep J Lab Clin Med 1995;126:24-28.
35. Terslappen LW, Huang S, Safford M, Lansdorp PM, Loken MR. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+ CD38- progenitor cells. Blood. 1991;77:1218-1227.
36. Traycoff CM, Abboud MR, Lauer J, et al. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp Hematol. 1994;22: 215-222.
37. Srour EF, Brandt JE, Briddell RA, Grigsby S, Leemhuis T, Hoffman R. Long-term generation and expansion of human primitive hematopoietic progenitor cells in vitro. Blood. 1993;81:661-669.